FDA.reportPublic FDA data

Atelvia 35 MG Delayed Release Oral Tablet Once-a-Week Pack

RxCUI
1020066
RxNorm name
Atelvia 35 MG Delayed Release Oral Tablet Once-a-Week Pack
Display name
Atelvia 35 MG Delayed Release Oral Tablet Once-a-Week Pack
Full name
Atelvia 35 MG Delayed Release Oral Tablet Once-a-Week Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AtelviaRISEDRONATE SODIUMAllergan, Inc.c8b9ab88-1a26-46c3-80ec-4eaa452020212026-02-03Warnings, Adverse reactionsExact identifier
rxcui: 1020066

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c8b9ab88-1a26-46c3-80ec-4eaa45202021{4 (risedronate sodium 35 MG Delayed Release Oral Tablet) } Pack [Atelvia] [BPCK] · Atelvia 35 MG Delayed Release Oral Tablet Once-a-Week Pack [PSN]229These highlights do not include all the information needed to use ATELVIA safely and effectively. See full prescribing information for ATELVIA . ATELVIA ® (risedronate sodium) delayed-release tablets Initial U.S. Approval: 199820260203